Company: SMNR
Filing Date: 2025-05-16
Form Type: 10-Q
Source: 0001213900-25-044889
Chunk: 68

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-05-16
Form: 10-Q
Item: Part I, Item 1
Chunk 68
---
Changes in Internal Control over Financial
Reporting

During the quarter ended March 31, 2025, there
has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially
affect, our internal control over financial reporting.

37

Part
II. OTHER INFORMATION

Item
1. LEGAL PROCEEDINGS.

None.

ITEM 1A. RISK FACTORS.

As of the date of this Quarterly Report, there
have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December
31, 2024 filed with the SEC on April 2, 2025 other than those set forth under "Risk Factors" in the Semnur Proxy Statement/Prospectus.

Item
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

Item
3. DEFAULTS UPON SENIOR SECURITIES.

None.

Item
4. MINE SAFETY DISCLOSURES.

Not applicable.

Item
5. OTHER INFORMATION.

None.

38

Item
6. EXHIBITS.

The following exhibits are filed as part of, or
incorporated by reference into, this Quarterly Report on Form 10-Q.

    No.
     
    Description of Exhibit
  
    31.1**
     
    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  
    31.2**
     
    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  
    32.1***
     
    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  
    32.2***
     
    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section